As the world recently marked World Aids Day, Africa Check has investigated the evidence behind three claims of an Aids breakthrough "cure".
Balancing traditional medicine and ARVs can be a challenge, even for a 21st-century healer.
Did you know some medicines are 60 times more expensive in SA than in many other countries? Our patent laws are one of the reasons behind these inflated prices.
Patients go without key drugs as the province and suppliers trade blame for antiretroviral shortages.
According to HIV prevention trial results, the daily use of pills or a vaginal gel does not appear to prevent HIV-infection in African women.
ARVs have slowed down the rate of new HIV infections and increased the life expectancy of the general population in rural KZN
Pressure's mounting on SA's Medicines Control Council to register the use of Truvada by the HIV-negative to lower chances of being infected with HIV.
Embarrassingly, Washington's infection rate tops that of some African countries, writes Sarah Boseley.
Although you can never stop taking antiretrovirals, rumours that these little pills will drive you mad are a bald-faced lie, writes Mia Malan.
Drug supplies are running low and a lack of funding could reverse important progress made in Swaziland's HIV/Aids crisis.
The United Nations says access to HIV treatment has improved greatly in sub-Saharan African, leading to a steady drop in Aids-related deaths.
A state-owned pharmaceutical company providing ARVs is not a clear remedy for cheaper and more efficient manufacturing of the life-saving medication.
National transmission rates of perinatal HIV infection are falling but the past is still with us, writes Martinique Stilwell.
If people knew their status, new infections would decrease. The question is how to achieve this.
Universal access to antiretroviral therapy could have saved more than 4,37-million children in Africa from becoming orphans.
An active approach to identifying TB at the community level is needed in a country with one of the highest rates of the disease in the world.
The M&G weighs in on its victory at the SCA and the government's extraordinary success in cutting in half the cost of antiretroviral drugs.
The new procurement procedures have succeeded in halving the cost of ARV drugs.
There has been a "massive reduction" in the prices of antiretroviral (ARV) drugs, according to Health Minister Aaron Motsoaledi.
Much has been done to combat HIV and Aids in Africa, but those gains are now in jeopardy.